Evidence map›Paper›PMID 29382317›Full record

ArticleBMC pulmonary medicine2018

The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study.

Damilya Nugmanova, Yuriy Feshchenko, Liudmyla Iashyna, Olga Gyrina, Kateryna Malynovska, Eljan Mammadbayov, Irada Akhundova, Nadezhda Nurkina, Luqman Tariq, Janina Makarova and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC pulmonary medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review.International journal of environmental research and public health · 2020
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Damilya NugmanovaSemey State Medical University, Almaty, Kazakhstan.
Yuriy FeshchenkoNational Institute of Phthisiology and Pulmonology F.G. Yanovsky of NAMS, Kiev, Ukraine.
Liudmyla IashynaNational Institute of Phthisiology and Pulmonology F.G. Yanovsky of NAMS, Kiev, Ukraine.
Olga GyrinaNational Medical University n.a. O.O. Bogomoletz, Kiev, Ukraine.
Kateryna MalynovskaGlaxoSmithKline, Kiev, Ukraine.
Eljan MammadbayovScientific Research Institute of Lung Diseases, Baku, Azerbaijan.
Irada AkhundovaScientific Research Institute of Lung Diseases, Baku, Azerbaijan.
Nadezhda NurkinaSemey State Medical University, Almaty, Kazakhstan.
Luqman TariqGlaxoSmithKline, Dubai, UAE.
Janina MakarovaGlaxoSmithKline, Moscow, Russia. yana.j.makarova@gsk.com.
Averyan VasylyevGlaxoSmithKline, Kiev, Ukraine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DustAdolescentAdultAgedAzerbaijanBody Mass IndexCardiovascular DiseasesComorbidityCross-Sectional StudiesFemaleForced Expiratory VolumeHumansHypertensionKazakhstanMaleMiddle AgedDustAzerbaijanChronic obstructive pulmonary disease (COPD)KazakhstanPrevalenceRisk factorsUkraine

Identifiers

PMID29382317
PMCPMC5791247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.